FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/05/019031 [Registered on: 09/05/2019] Trial Registered Prospectively
Last Modified On: 08/05/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Single Arm Study 
Public Title of Study   A clinical study on Kodiveli chooranam for Vali Azhal Keel Vayu(Rheumatoid Arthritis) 
Scientific Title of Study   A Prospective open labelled phase-II Non-randomized clinical trial on kodiveli chooranam for the tratment of Vali Azhal Keel Vayu(Rheumatoid Arthritis) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  R Srikajan 
Designation  PG Scholar 
Affiliation  Govt Siddha Medical College and Hospital 
Address  Department of Pothu Maruthuvam Govt Siddha Medical College and Hospital Palayamkottai Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9384121796  
Fax    
Email  srikajan1978@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr A Manoharan MD PhD 
Designation  Professor and HOD 
Affiliation  Govt Siddha Medical College and Hospital 
Address  Department of Pothu Maruthuvam Govt Siddha Medical College and Hospital Palayamkottai Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9443886700  
Fax    
Email  drmanoharan25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr T Komalavalli MD PhD 
Designation  Associate Professor 
Affiliation  Govt Siddha Medical College and Hospital 
Address  Department of Pothu Maruthuvam Govt Siddha Medical College and Hospital Palayamkottai Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9788122691  
Fax    
Email  komalaarumugam1@gmail.com  
 
Source of Monetary or Material Support  
IPD and OPD facilities and central library of Govt Siddha Medical College and Hospital  
 
Primary Sponsor  
Name  Govt Siddha Medical College and Hospital 
Address  Palayamokottai Tirunelveli TamilNadu 627002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
R Srikajan  Govt Siddha Medical College and Hospital  OP Number10 PG Department of Pothu maruthuvam Govt Siddha Medical College and Hospital Palayamkottai
Tirunelveli
TAMIL NADU 
9384121796

srikajan1978@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M059||Rheumatoid arthritis with rheumatoid factor, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Kodiveli Chooranam  20mg/kg/Body weight BD B/F with water for 45 days 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Symmetrical joint involvement
2.Involvement of 3 or more joints
3.Florid morning stiffness and swelling that lasts for few hours or days
4.Pain, joint swelling especially in the interphalangeal joints
5.Pain criteria score should be greater than or equal to 6. 
 
ExclusionCriteria 
Details  1.Psoriatic arthritis
2.Gout
3.Mixed connective tissue disorders
4.SLE
5.Extra pulmonary tuberculosis 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.Reducing the pain, swelling, early morning stiffness, deformities.
2.To assess improvement based on the disease activity pain score. 
45days 
 
Secondary Outcome  
Outcome  TimePoints 
1.Evaluation of addition effects and siddha parameters during trial period
2.Determination of safety profile of trial drug
3.Evaluation of Bio chemical investigation parameters 
45days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   13/05/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   The study is a  prospective open labelled phase II non -randomized clinical study to evaluate the therapeutic efficacy of  KODIVELI CHOORANAM  in the management of  vali azhal keel vayu (Rheumatoid arthritis).The trial drug will be administered at the dose of 20mg/kg/Body weight BD before food along with water as adjuvant for 45 days in 40 patients. The trial period of 12 months will be carrying out in Government Siddha Medical College and Hospital Palayamkottai Tirunelveli TamilNadu. The Primary out come will be the evaluation of therapeutic efficacy of trial drug KODIVELI CHOORANAM . The secondary outcome will be the evaluation of Siddha diagnostic parameters,assessment of  safety profile of trial drug,assessment of  pharmacological and biochemical parameters of trial drug 
Close